N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141255 |
| CAS No | NA |
| Mol.F. | C10H12Cl3N3O |
| Mol.Wt. | 296.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141256 |
| CAS No | NA |
| Mol.F. | C10H12Cl3N3O |
| Mol.Wt. | 296.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141257 |
| CAS No | NA |
| Mol.F. | C10H11Cl3N4O2 |
| Mol.Wt. | 325.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141258 |
| CAS No | NA |
| Mol.F. | C11H16ClN3O2 |
| Mol.Wt. | 257.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141259 |
| CAS No | NA |
| Mol.F. | C23H26Cl2N4O3 |
| Mol.Wt. | 477.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141260 |
| CAS No | NA |
| Mol.F. | C23H26Cl2N4O4 |
| Mol.Wt. | 493.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141261 |
| CAS No | 14026-03-0 |
| Mol.F. | C6H12N2O |
| Mol.Wt. | 128.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141262 |
| CAS No | NA |
| Mol.F. | C14H15N3O4 |
| Mol.Wt. | 289.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141263 |
| CAS No | NA |
| Mol.F. | C9H5N3O |
| Mol.Wt. | 171.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141264 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O2 |
| Mol.Wt. | 275.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141265 |
| CAS No | NA |
| Mol.F. | C13H12ClN3O |
| Mol.Wt. | 261.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141266 |
| CAS No | 2512217-82-0 |
| Mol.F. | C15H17N3O4 |
| Mol.Wt. | 303.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141267 |
| CAS No | NA |
| Mol.F. | C8H5N2O4S : Na |
| Mol.Wt. | 225.2 : 23.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141268 |
| CAS No | 1000399-11-0 |
| Mol.F. | C8H5BrN2O |
| Mol.Wt. | 225.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141269 |
| CAS No | NA |
| Mol.F. | C13H11N3O3 |
| Mol.Wt. | 257.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141271 |
| CAS No | NA |
| Mol.F. | C13H14N4O3 |
| Mol.Wt. | 274.3 |
| INV STATUS | In Stock |